BVMF/BALM3 (BVMF/BALM3)

Brazil Stock Exchange: BVMF/BALM3 · BRL

R$22.0

+0.00 (0.0%)· Recorded snapshot

Market cap	180.1M
Revenue (ttm)	205.2M
Net income (ttm)	22.6M
EPS (ttm)	R$2.31
P/E (trailing)	9.5x
Dividend	R$4.68 (21.27%)
Volume	0
Beta	0.36

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 205.2M
Net income (ttm): 22.6M
EPS (ttm): R$2.31
P/E (trailing): 9.5x
Market cap: 180.1M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-30 13:30 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E9.5

P25 n/aP50 n/aP75 n/a

ROE14.8

P25 n/aP50 n/aP75 n/a

ROIC24.5

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BVMF/BALM3 indicators

Market & fundamental data

Available fields

233

Groups with data

Currency

BRL

Showing 233 of 233 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	BRL
Country	Brazil
Country code	BR
Earnings date	2026-11-13
Employees	306
Enterprise value	BRL 130.7M
Exchange	Brazil Stock Exchange
Financial currency	BRL
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1952
Industry	Medical Instruments & Supplies
Is primary listing	No
ISIN number	BRBALMACNOR5
Last earnings date	2025-11-11
Last refreshed	2026-10-30
Last stock split date	2014-05-02
Last stock split type	Forward
Market cap	BRL 180.1M
Next earnings date	2026-11-13
Price	BRL 22.00
Price currency	BRL
Sector	Healthcare
SIC code	3842
Stock price date	2026-10-30
Symbol	bvmf/BALM3
Website	https://www.baumer.com.br

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	22.96x
Average P/E ratio (3Y)	7.88x
Average P/E ratio (5Y)	11.33x
Earnings yield	10.5%
EV/Earnings	5.78x
EV/EBIT	3.72x
EV/EBITDA	3.18x
EV/FCF	4.22x
EV/Sales	0.64x
FCF / EV yield	23.7%
FCF yield	17.2%
Graham number	34.97908
Graham upside	59%
Lynch fair value	BRL 69.03
Lynch upside	213.78%
P/B ratio	1.12x
P/E ratio	9.53x
P/FCF ratio	5.81x
P/OCF ratio	4.31x
P/S ratio	0.88x
Price / tangible book value	1.08x
Price/EBITDA ratio	4.43x
Sector forward P/E	10.79x
Sector P/E	32.27x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	16.86%
EBITDA margin	19.8%
Effective tax rate	20.99%
FCF margin	15.09%
Gross margin	63.85%
Operating margin	16.86%
Pretax margin	15.67%
Profit margin	11.01%
Profit per employee	BRL 73,853
Profitable quarters	11
Profitable years	23
Revenue per employee	BRL 670,722
ROA	7.46%
ROA (5Y)	6.2%
ROCE	16.35%
ROE	14.83%
ROE (5Y)	10.19%
ROIC	24.55%
ROIC (5Y)	16.44%
Tax / revenue	3.29%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	-20.57%
EPS growth (Q)	65.79%
EPS growth (QoQ)	81.95%
EPS growth 10Y	12.61%
EPS growth 3Y	101.19%
EPS growth 5Y	28.88%
EPS growth quarters	1
EPS growth years	0
FCF growth	10.18%
FCF growth (Q)	-72.84%
FCF growth (QoQ)	-6.07%
FCF growth 3Y	37.75%
FCF growth 5Y	8.37%
Gross profit growth	-3.35%
Gross profit growth (Q)	-8.84%
Gross profit growth 3Y	7.12%
Gross profit growth 5Y	10.81%
Net income growth	-20.57%
Net income growth (Q)	65.79%
Net income growth (QoQ)	81.95%
Net income growth 3Y	101.19%
Net income growth 5Y	28.88%
Net income growth quarters	2
Net income growth years	0
OCF growth	12.11%
OCF growth (Q)	-73.45%
OCF growth (QoQ)	-42.47%
OCF growth 10Y	24.3%
OCF growth 3Y	29.91%
OCF growth 5Y	10.77%
Operating income growth	-28.18%
Operating income growth (Q)	-35.48%
Operating income growth 3Y	24.2%
Operating income growth 5Y	22.92%
Revenue growth	-6.01%
Revenue growth (Q)	-12.49%
Revenue growth (QoQ)	4.28%
Revenue growth 10Y	6.56%
Revenue growth 3Y	3.97%
Revenue growth 5Y	6.99%
Revenue growth years	2

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	BRL -10.8M
Depreciation and amortization	BRL 6M
EBIT	BRL 34.6M
EBITDA	BRL 40.6M
EPS	BRL 2.31
Financing cash flow	BRL -46.3M
Free cash flow	BRL 31M
Gross profit	BRL 131.1M
Income taxes	BRL 6.8M
Investing cash flow	BRL -8.2M
Net borrowing	BRL 5.7M
Net cash flow	BRL -12.8M
Net income	BRL 22.6M
Operating income	BRL 34.6M
Revenue	BRL 205.2M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	3.06
Book value per share	BRL 17.16
Debt / EBITDA	0.69
Debt / equity	0.17
Debt / FCF	0.9
Interest coverage	1.39
Long-term assets	BRL 75.7M
Long-term liabilities	BRL 50.4M
Net cash (debt)	BRL 42.7M
Net cash / market cap	23.7%
Net cash growth	-30.16%
Net debt / EBITDA	-1.05
Net debt / equity	-0.26
Net debt / FCF	-1.38
Piotroski F-Score	5
Property, plant and equipment	BRL 40.7M
Shareholders' equity	BRL 161.2M
Tangible book value	BRL 166.7M
Tangible book value per share	BRL 17.03
Total assets	BRL 292M
Total cash	BRL 70.6M
Total debt	BRL 28M
Total liabilities	BRL 130.8M
WACC	14.85%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.71
Current assets	BRL 216.2M
Current liabilities	BRL 80.4M
Current ratio	2.69
Inventory turnover	1.06
Net working capital	BRL 67.2M
Quick ratio	1.67
Working capital	BRL 135.9M
Working capital turnover	1.44

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend growth	274.4%
Dividend growth (10Y)	28.21%
Dividend growth (3Y)	186.03%
Dividend growth (5Y)	50.81%
Dividend growth years	1
Dividend payment date	2026-12-30
Dividend payment years	23
Dividend payout frequency	Semi-Annual
Dividend per share	BRL 4.68
Dividend yield	21.27%
Ex-dividend date	2026-05-04
Last dividend	BRL 0.82
Payout ratio	230.11%
Shareholder yield	21.27%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	BRL 18.05
1D price change	0%
1M price change	-15.06%
1M total return	-15.06%
1Y price change	5.26%
1Y return CAGR	19.86%
1Y total return	19.84%
20-day SMA	BRL 24.20
200-day SMA	BRL 16.13
3M price change	-15.38%
3M total return	-15.38%
3Y price change	102.02%
3Y return CAGR	40.23%
3Y total return	175.84%
50-day SMA	BRL 25.06
50-day SMA vs 200-day SMA	50over200
52-week high	BRL 33.00
52-week high date	2025-12-17
52-week low	BRL 20.90
52-week low date	2025-11-03
5Y price change	29.41%
5Y return CAGR	12.87%
5Y total return	83.14%
6M price change	-15.38%
6M total return	-12.63%
All-time high	BRL 35.40
All-time high date	2020-07-14
All-time low	BRL 5.31
All-time low date	2017-07-11
Average true range (ATR)	BRL 0.33
Average volume	650
Beta (5Y)	0.36
Change from 52-week high	-33.33%
Change from 52-week low	5.26%
Change from all-time high	-37.85%
Change from all-time low	314.31%
Change from open	0%
Day's gap	0%
High price	BRL 22.00
Low price	BRL 22.00
Monthly RSI	54.57
Open price	BRL 22.00
Previous close	BRL 22.00
Price vs 150-day SMA	21.86%
Price vs 20-day SMA	-9.07%
Price vs 200-day SMA	36.36%
Price vs 50-day SMA	-12.22%
Relative volume	0.15
RSI	26.84
Sharpe ratio	1.26
Sortino ratio	2.12
Volume	0
Weekly RSI	54.94
YTD price change	-21.43%
YTD total return	-18.87%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	3.5M
Shares change (QoQ)	0%
Shares held by insiders	38.46%

Deeper analysis on BVMF/BALM3

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BVMF/BALM3 report

Is a complete BVMF/BALM3 research report available?

No complete published report is available for bvmf/BALM3 (BVMF/BALM3) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BVMF/BALM3 (BVMF/BALM3)

Price

Financial snapshot

Fair-value bridge

Latest news · BVMF/BALM3

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BVMF/BALM3 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BVMF/BALM3

Frequently asked questions